Overview
Hanting Li practices practicing medicine in Wuhan, China.
Their clinical expertise encompasses Lung Adenocarcinoma, Chickenpox, Lung Cancer, and Familial Hypertrophic Cardiomyopathy.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hanting Li
Is Hanting Li a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Hanting Li is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hanting Li participate in research or clinical trials?
Yes. Hanting Li has published 21 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Hanting Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ChickenpoxLi isExperienced. Learn about Chickenpox.
- Familial Hypertrophic Cardiomyopathy
- Lung AdenocarcinomaLi isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerLi isExperienced. Learn about Lung Cancer.
- Lung NodulesLi isExperienced. Learn about Lung Nodules.
- Lymphofollicular Hyperplasia